Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Shanghai Pharmaceutical And Japan Suzuken Establish Joint Venture

This article was originally published in PharmAsia News

Executive Summary

Shanghai Pharmaceutical Co. and Suzuken, Japan's second largest pharmaceutical wholesaler, have officially launched their 50-50 venture. According to Shanghai Pharmaceutical, the new Shanghai-Suzuken company aims to become the first brand name in China to provide pharmaceutical distribution services. In the first year, sales revenue and net profits are estimated to increase by 20 and 30 percent respectively compared to its previous entity. This venture's rate of return tops the local pharmaceutical business equity transfer and Shanghai Pharmaceutical is confident that the collaboration will maximize its short- to long-term interests. Suzuken will introduce its established Japanese products, sales support system, management consulting system and other value-added services to enhance the new firm's competitiveness. (Click here for more - Chinese Language)
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC068094

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel